Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oza

Showing results (761-770 of 1,427) with videos related to

Pageof 143
Sort By:
Molecules (Basel, Switzerland)|November 18, 2018
Multidisciplinary Investigations on <i>Galphimia glauca</i>: A Mexican Medicinal Plant with Pharmacological PotentialAshutosh Sharma, Paola Isabel Angulo-Bejarano, Alfredo Madariaga-Navarrete, et al.
BMC Cancer|October 7, 2011
Early mortality and overall survival in oncology phase I trial participants: can we improve patient selection?Nicole G Chau, Ana Florescu, Kelvin K Chan, et al.
Heart Rhythm|February 15, 2011
Temporal stability of defibrillation thresholds with cardiac resynchronization therapyMichael R Gold, Amir Hedayati, Jamshid Alaeddini, et al.
European Journal of Cancer (Oxford, England : 1990)|March 23, 2010
Prognostic value of microsatellite instability (MSI) and PTEN expression in women with endometrial cancer: results from studies of the NCIC Clinical Trials Group (NCIC CTG)Helen J Mackay, Steven Gallinger, Ming S Tsao, et al.
The Journal of the Association of Physicians of India|November 1, 1994
Sickle cell syndromes in and around BardoliS R Iyer, R R Iyer, G D Oza, et al.
Emerging Infectious Diseases|October 20, 2017
Symptom- and Laboratory-Based Ebola Risk Scores to Differentiate Likely Ebola InfectionsShefali Oza, Alieu A Sesay, Neal J Russell, et al.
British Journal of Cancer|August 14, 2003
Phase I study of cisplatin, irinotecan, and epirubicin administered every 3 weeks in patients with advanced solid tumoursX Chen, A M Oza, Z Kusenda, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 18, 2010
Sorafenib in combination with gemcitabine in recurrent epithelial ovarian cancer: a study of the Princess Margaret Hospital Phase II ConsortiumStephen A Welch, Hal W Hirte, Laurie Elit, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|August 3, 2022
Factors influencing engagement in hospital-based exercise oncology programs: A narrative reviewEmily R Dunston, Pendeza B Mulibea, Jonathan Chipman, et al.
Plants (Basel, Switzerland)|December 28, 2021
Concentration of Nutrients in Leaves, Flowers, and Fruits of Genotypes of <i>Coffea canephora</i>Millena Monteiro Dos Santos, Cleidson Alves da Silva, Eduardo France Oza, et al.
Pageof 143

Showing results (761-770 of 1,427) with videos related to

Sort By:
Pageof 143
Molecules (Basel, Switzerland)|November 18, 2018
Multidisciplinary Investigations on <i>Galphimia glauca</i>: A Mexican Medicinal Plant with Pharmacological PotentialAshutosh Sharma, Paola Isabel Angulo-Bejarano, Alfredo Madariaga-Navarrete, et al.
BMC Cancer|October 7, 2011
Early mortality and overall survival in oncology phase I trial participants: can we improve patient selection?Nicole G Chau, Ana Florescu, Kelvin K Chan, et al.
Heart Rhythm|February 15, 2011
Temporal stability of defibrillation thresholds with cardiac resynchronization therapyMichael R Gold, Amir Hedayati, Jamshid Alaeddini, et al.
European Journal of Cancer (Oxford, England : 1990)|March 23, 2010
Prognostic value of microsatellite instability (MSI) and PTEN expression in women with endometrial cancer: results from studies of the NCIC Clinical Trials Group (NCIC CTG)Helen J Mackay, Steven Gallinger, Ming S Tsao, et al.
The Journal of the Association of Physicians of India|November 1, 1994
Sickle cell syndromes in and around BardoliS R Iyer, R R Iyer, G D Oza, et al.
Emerging Infectious Diseases|October 20, 2017
Symptom- and Laboratory-Based Ebola Risk Scores to Differentiate Likely Ebola InfectionsShefali Oza, Alieu A Sesay, Neal J Russell, et al.
British Journal of Cancer|August 14, 2003
Phase I study of cisplatin, irinotecan, and epirubicin administered every 3 weeks in patients with advanced solid tumoursX Chen, A M Oza, Z Kusenda, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 18, 2010
Sorafenib in combination with gemcitabine in recurrent epithelial ovarian cancer: a study of the Princess Margaret Hospital Phase II ConsortiumStephen A Welch, Hal W Hirte, Laurie Elit, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|August 3, 2022
Factors influencing engagement in hospital-based exercise oncology programs: A narrative reviewEmily R Dunston, Pendeza B Mulibea, Jonathan Chipman, et al.
Plants (Basel, Switzerland)|December 28, 2021
Concentration of Nutrients in Leaves, Flowers, and Fruits of Genotypes of <i>Coffea canephora</i>Millena Monteiro Dos Santos, Cleidson Alves da Silva, Eduardo France Oza, et al.
Pageof 143